Bioinformatic analysis of drug targets for triple-negative breast cancer
Main Authors: | Xiao-Wei Li, Chun-Bo Kang, Xiao-Qian Chi, Tie-Jun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Asian Journal of Surgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958422012027 |
Similar Items
-
Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer
by: Jeremy Johnson, et al.
Published: (2020-05-01) -
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
by: Po-Han Lin, et al.
Published: (2022-12-01) -
In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model
by: Jinrong Lin, et al.
Published: (2023-11-01) -
Dysregulated Gab1 signalling in triple negative breast cancer
by: Hannes Bongartz, et al.
Published: (2024-03-01) -
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
by: Xuemei Xie, et al.
Published: (2023-02-01)